Sparian Biosciences
New York
About Sparian Biosciences
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique, transformative medicines for the central nervous system. They develop therapeutics targeting the brain through innovative science and novel drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $19.5M
- Last round: Grant (Nov 2024)
- Website: sparianbiosciences.com
Industries & Categories
Biotechnology, Consulting, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sparian-biosciences-151365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.